āĻšā§āĻŽBCRX âĸ NASDAQ
add
BioCryst Pharmaceuticals Inc
ā§§ā§Ļ.ā§¨ā§Ē$
āĻāĻŖā§āĻāĻž āĻĒāĻ°ā§:(ā§Ļ.ā§ā§Ž%)-ā§Ļ.ā§Ļā§Žā§Ļ
ā§§ā§Ļ.ā§§ā§Ŧ$
āĻŦāĻ¨ā§āĻ§ āĻāĻā§: ā§§ā§Ŧ āĻŽā§, ā§:ā§§ā§¨:ā§Šā§¯ PM GMT -ā§Ē · USD · NASDAQ · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻ¸ā§āĻāĻāĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ āĻ¯ā§āĻā§āĻ¤āĻ°āĻžāĻˇā§āĻā§āĻ°-āĻ āĻ¤āĻžāĻ˛āĻŋāĻāĻžāĻā§āĻā§āĻ¤ āĻ¸āĻŋāĻāĻŋāĻāĻ°āĻŋāĻāĻŋāĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ āĻ¯ā§āĻā§āĻ¤āĻ°āĻžāĻˇā§āĻā§āĻ°-āĻ āĻšā§āĻĄāĻā§ā§āĻžāĻ°ā§āĻāĻžāĻ°
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§§ā§Ļ.ā§¨ā§§$
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§§ā§Ļ.ā§§ā§¨$ - ā§§ā§Ļ.ā§Šā§Ž$
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§Ģ.ā§¯ā§¨$ - ā§§ā§§.ā§§ā§§$
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§¨ā§§ā§Ē.ā§¨ā§Â āĻā§ USD
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§Ģā§.ā§Ēā§ĢÂ āĻ˛āĻž
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
-
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
-
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
NASDAQ
āĻāĻŦāĻ°ā§ āĻ°ā§ā§āĻā§
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (USD) | āĻŽāĻžāĻ°ā§āĻ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§§ā§Ē.ā§Ģā§Ģ āĻā§ | ā§Ģā§Ŧ.ā§Žā§¯% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§Ž.ā§¨ā§Ģ āĻā§ | ā§Šā§Ž.ā§Ŧā§¨% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§Šā§¨.ā§Ļā§Ļ āĻšāĻž | ā§§ā§Ļā§Ļ.ā§Ļā§¯% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | ā§Ļ.ā§Ļā§¨ | ā§§ā§Ļā§Ļ.ā§Ļā§Ģ% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§Ļ.ā§Ļā§Ļ | ā§§ā§Ļā§Ļ.ā§Ļā§Ļ% |
EBITDA | ā§¨.ā§§ā§Ŧ āĻā§ | ā§¨ā§Ģā§¨.ā§Ļā§§% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | ā§¯ā§Ģ.ā§ā§Ž% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (USD) | āĻŽāĻžāĻ°ā§āĻ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§¨ā§¯.ā§Ģā§§Â āĻā§ | -ā§§ā§¨.ā§Šā§¨% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§Ēā§Ž.ā§Ļā§Ļ āĻā§ | ā§¨.ā§Ŧā§Ļ% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§¯ā§Š.ā§¨ā§Ļ āĻā§ | -ā§§.ā§¨ā§Ž% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | -ā§Ēā§Ģ.ā§§ā§¯Â āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§¨ā§Ļ.ā§¯ā§ŠÂ āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | -ā§Ē.ā§ā§Š | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§§ā§Ļ.ā§¯ā§Ē% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | ā§§ā§Ē.ā§¨ā§¯% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (USD) | āĻŽāĻžāĻ°ā§āĻ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§Šā§¨.ā§Ļā§Ļ āĻšāĻž | ā§§ā§Ļā§Ļ.ā§Ļā§¯% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | -ā§¨.ā§ā§Ģ āĻā§ | ā§Ēā§Ž.ā§ā§Ē% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§¨.ā§ā§§Â āĻā§ | -ā§Ģ.ā§ā§Ž% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§Ģ.ā§¨ā§¯Â āĻ˛āĻž | ā§§ā§Ģā§Ļ.ā§Ēā§Ž% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | ā§Ģ.ā§Ģā§ŽÂ āĻ˛āĻž | ā§§ā§Ļā§¨.ā§§ā§¨% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | -ā§§.ā§Ģā§¯Â āĻā§ | ā§Ŧā§Ŧ.ā§Ļā§¯% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
āĻ¸āĻŋāĻāĻ
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§§ā§¯ā§Žā§Ŧ
āĻ¸āĻĻāĻ° āĻĻāĻĒā§āĻ¤āĻ°
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§Ģā§Žā§Ļ
